The AKT1 isoform plays a dominant role in the survival and chemoresistance of chronic lymphocytic leukaemia cells.

Sebastian Hofbauer; Peter Krenn; Josefina Piñόn Hofbauer; Susanne Pucher; Daniela Asslaber; Alexander Egle; Tanja Hartmann; Richard Greil

doi:10.1111/bjh.13542

The AKT1 isoform plays a dominant role in the survival and chemoresistance of chronic lymphocytic leukaemia cells.

Sebastian Hofbauer (Erstautor/-in), Peter Krenn (Erstautor/-in), Josefina Piñόn Hofbauer (Co-Autor/-in), Susanne Pucher (Co-Autor/-in), Daniela Asslaber (Co-Autor/-in), Alexander Egle (Co-Autor/-in), Tanja Hartmann^* (Co-Autor/-in), Richard Greil (Letztautor/-in)

^*Korrespondierende/r Autor/-in für diese Arbeit

Universitätsklinik für Innere Medizin 3 - Hämatologie, internistische Onkologie, Hämostaseologie, Infektiologie, Rheumatologie und Onkologisches Zentrum

Publikation: Beitrag in Fachzeitschrift › Letter to the editor › Begutachtung

8 Quellenangaben (Web of Science)

Originalsprache	Englisch
Seiten (von - bis)	815-819
Fachzeitschrift	BRITISH JOURNAL OF HAEMATOLOGY
Jahrgang	172
Ausgabenummer	5
DOIs	https://doi.org/10.1111/bjh.13542
Publikationsstatus	Veröffentlicht - 2016

Zugriff auf Dokument

10.1111/bjh.13542

Dieses zitieren

Hofbauer, S., Krenn, P., Piñόn Hofbauer, J., Pucher, S., Asslaber, D., Egle, A., Hartmann, T., & Greil, R. (2016). The AKT1 isoform plays a dominant role in the survival and chemoresistance of chronic lymphocytic leukaemia cells. BRITISH JOURNAL OF HAEMATOLOGY , 172(5), 815-819. https://doi.org/10.1111/bjh.13542

Hofbauer, Sebastian ; Krenn, Peter ; Piñόn Hofbauer, Josefina et al. / The AKT1 isoform plays a dominant role in the survival and chemoresistance of chronic lymphocytic leukaemia cells. in: BRITISH JOURNAL OF HAEMATOLOGY 2016 ; Jahrgang 172, Nr. 5. S. 815-819.

@article{92eb2accc4d64be7b79c5b6411b73f3f,

title = "The AKT1 isoform plays a dominant role in the survival and chemoresistance of chronic lymphocytic leukaemia cells.",

keywords = "ESSENTIAL THROMBOCYTHEMIA, CALRETICULIN MUTATIONS, CALR MUTATION, JAK2, MYELOFIBROSIS, THROMBOSIS, PLATELET, RISK",

author = "Sebastian Hofbauer and Peter Krenn and {Pi{\~n}όn Hofbauer}, Josefina and Susanne Pucher and Daniela Asslaber and Alexander Egle and Tanja Hartmann and Richard Greil",

note = "alle: Laboratory for Immunological and Molecular Cancer Research, 3rd Medical Department with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncological Centre, Paracelsus Medical University, Salzburg, Austria",

year = "2016",

doi = "10.1111/bjh.13542",

language = "English",

volume = "172",

pages = "815--819",

journal = "BRITISH JOURNAL OF HAEMATOLOGY ",

issn = "0007-1048",

number = "5",

}

Hofbauer, S, Krenn, P, Piñόn Hofbauer, J, Pucher, S, Asslaber, D, Egle, A, Hartmann, T & Greil, R 2016, 'The AKT1 isoform plays a dominant role in the survival and chemoresistance of chronic lymphocytic leukaemia cells.', BRITISH JOURNAL OF HAEMATOLOGY , Jg. 172, Nr. 5, S. 815-819. https://doi.org/10.1111/bjh.13542

The AKT1 isoform plays a dominant role in the survival and chemoresistance of chronic lymphocytic leukaemia cells. / Hofbauer, Sebastian (Erstautor/-in); Krenn, Peter (Erstautor/-in); Piñόn Hofbauer, Josefina (Co-Autor/-in) et al.
in: BRITISH JOURNAL OF HAEMATOLOGY , Jahrgang 172, Nr. 5, 2016, S. 815-819.

Publikation: Beitrag in Fachzeitschrift › Letter to the editor › Begutachtung

TY - JOUR

T1 - The AKT1 isoform plays a dominant role in the survival and chemoresistance of chronic lymphocytic leukaemia cells.

AU - Hofbauer, Sebastian

AU - Krenn, Peter

AU - Piñόn Hofbauer, Josefina

AU - Pucher, Susanne

AU - Asslaber, Daniela

AU - Egle, Alexander

AU - Hartmann, Tanja

AU - Greil, Richard

N1 - alle: Laboratory for Immunological and Molecular Cancer Research, 3rd Medical Department with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncological Centre, Paracelsus Medical University, Salzburg, Austria

PY - 2016

Y1 - 2016

KW - ESSENTIAL THROMBOCYTHEMIA

KW - CALRETICULIN MUTATIONS

KW - CALR MUTATION

KW - JAK2

KW - MYELOFIBROSIS

KW - THROMBOSIS

KW - PLATELET

KW - RISK

U2 - 10.1111/bjh.13542

DO - 10.1111/bjh.13542

M3 - Letter to the editor

C2 - 26147087

SN - 0007-1048

VL - 172

SP - 815

EP - 819

JO - BRITISH JOURNAL OF HAEMATOLOGY

JF - BRITISH JOURNAL OF HAEMATOLOGY

IS - 5

ER -

Hofbauer S, Krenn P, Piñόn Hofbauer J, Pucher S, Asslaber D, Egle A et al. The AKT1 isoform plays a dominant role in the survival and chemoresistance of chronic lymphocytic leukaemia cells. BRITISH JOURNAL OF HAEMATOLOGY . 2016;172(5):815-819. doi: 10.1111/bjh.13542